A clinicopathological approach to the diagnosis of dementia
FM Elahi, BL Miller - Nature Reviews Neurology, 2017 - nature.com
The most definitive classification systems for dementia are based on the underlying
pathology which, in turn, is categorized largely according to the observed accumulation of …
pathology which, in turn, is categorized largely according to the observed accumulation of …
[HTML][HTML] Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
KL Lanctôt, J Amatniek, S Ancoli-Israel… - Alzheimer's & Dementia …, 2017 - Elsevier
Neuropsychiatric symptoms (NPSs) are hallmarks of Alzheimer's disease (AD), causing
substantial distress for both people with dementia and their caregivers, and contributing to …
substantial distress for both people with dementia and their caregivers, and contributing to …
[HTML][HTML] Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
Alzheimer's Disease (AD) is a chronic neurodegenerative disorder and the most common
type of dementia (60–80% of cases). In 2016, nearly 44 million people were affected by AD …
type of dementia (60–80% of cases). In 2016, nearly 44 million people were affected by AD …
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
CPC Galts, LEB Bettio, DC Jewett, CC Yang… - Neuroscience & …, 2019 - Elsevier
Major depressive disorder (MDD) is a highly prevalent psychiatric disorder and a major
cause of disability worldwide. This neurological condition is commonly associated with …
cause of disability worldwide. This neurological condition is commonly associated with …
[HTML][HTML] The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease
Alzheimer's disease (AD) is neuropathologically characterized by the intracellular
accumulation of hyperphosphorylated tau and the extracellular deposition of amyloid-β …
accumulation of hyperphosphorylated tau and the extracellular deposition of amyloid-β …
[HTML][HTML] The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review
E Aaldijk, Y Vermeiren - Ageing Research Reviews, 2022 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia, accounting for more than
50 million patients worldwide. Current evidence suggests the exact mechanism behind this …
50 million patients worldwide. Current evidence suggests the exact mechanism behind this …
[HTML][HTML] Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease
SC Kelly, B He, SE Perez, SD Ginsberg… - Acta neuropathologica …, 2017 - Springer
A major feature of Alzheimer's disease (AD) is the loss of noradrenergic locus coeruleus
(LC) projection neurons that mediate attention, memory, and arousal. However, the extent to …
(LC) projection neurons that mediate attention, memory, and arousal. However, the extent to …
Sleep-disordered breathing and the risk of Alzheimer's disease
C Liguori, M Maestri, M Spanetta, F Placidi… - Sleep Medicine …, 2021 - Elsevier
Sleep-disordered breathing is highly prevalent in the elderly population. Obstructive sleep
apnea (OSA) represents the most common sleep disorder among the adult and elderly …
apnea (OSA) represents the most common sleep disorder among the adult and elderly …
Lymphatic drainage system of the brain: a novel target for intervention of neurological diseases
BL Sun, L Wang, T Yang, J Sun, L Mao, M Yang… - Progress in …, 2018 - Elsevier
The belief that the vertebrate brain functions normally without classical lymphatic drainage
vessels has been held for many decades. On the contrary, new findings show that functional …
vessels has been held for many decades. On the contrary, new findings show that functional …
[HTML][HTML] Mild behavioral impairment is associated with atrophy of entorhinal cortex and hippocampus in a memory clinic cohort
V Matuskova, Z Ismail, T Nikolai, H Markova… - Frontiers in aging …, 2021 - frontiersin.org
Objectives Mild behavioral impairment (MBI) is a syndrome describing late-onset persistent
neuropsychiatric symptoms (NPS) in non-demented older adults. Few studies to date have …
neuropsychiatric symptoms (NPS) in non-demented older adults. Few studies to date have …